ArticleScientific reports2025
AttenUNeT X with iterative feedback mechanisms for robust deep learning skin lesion segmentation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate skin lesion segmentation is critical for improving early diagnosis of skin cancer. In this study, we propose AttenUNeT X, a novel extension of the U-Net architecture that integrates three key enhancements: (i) a feedback mechanism within decoder blocks to iteratively refine spatial features, (ii) a custom Order Statistics Layer (OSL) to capture extreme-value lesion patterns, and (iii) enhanced attention modules to prioritize diagnostically relevant regions. These progresses improve segmentation performance by allowing for a targeted reaction to important lesion features. These additions work in synergy to improve boundary precision and contextual learning. The model was trained and validated using the International Skin Imaging Collaboration (ISIC 2018) Dataset, with PH2-Pedro Hispano Hospital Dataset was experimented for comparative analysis and ISIC 2017 used for external testing and cross-validation, respectively and guarantee dependable performance across a range of images distributions. Our preprocessing pipeline included hair removal, resizing, normalization, and extensive data augmentation to promote robustness. To facilitate model generalizability, the preprocessing pipeline featured data augmentation and images enhancement, and the attention-augmented encoder-decoder layers of the design highlighted key lesion features. Experimental results demonstrate strong performance, achieving a Dice coefficient of 0.9211, Intersection over Union (IoU) of 0.8533, and pixel accuracy of 0.9824 on ISIC 2018. Similarly high metrics were observed on PH2 and ISIC 2017 Datasets. These outcomes validate the proposed model's potential for reliable deployment in clinical dermatological workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.